Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Virax Biolabs Group Limited - SIC # 7352 - MEDICAL EQUIPMENT RENTAL AND LEASING
Ticker
Exchange
SIC #
Website
Latest Ticker
VRAX
Nasdaq
7352
viraxbiolabs.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Virax Biolabs Group Limited
Avalon Advanced Materials and Virax Biolabs Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
- May 15th, 2026 7:00 am
Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders
- Apr 14th, 2026 5:34 am
Virax Biolabs Group Limited (VRAX) Upgraded to Buy: Here's Why
- Jan 15th, 2026 10:00 am
Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement
- Dec 4th, 2025 2:05 pm
Virax Biolabs Group Limited Announces $5 Million Private Placement
- Dec 3rd, 2025 11:53 am
BC-Most Active Stocks
- Dec 3rd, 2025 8:30 am
Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders
- Dec 3rd, 2025 5:34 am
Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes
- Nov 3rd, 2025 6:29 am
Virax Biolabs (VRAX) Falls 18% on Lack of Leads
- Aug 27th, 2025 10:05 am
Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September
- Aug 26th, 2025 5:30 am
EXCLUSIVE: Virax Biolabs Inks Research Pact To Advance Long COVID Diagnostic Studies
- Aug 26th, 2025 5:15 am
Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy
- Jul 29th, 2025 5:35 am
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
- Jul 18th, 2025 2:15 pm
Virax Biolabs Group Full Year 2025 Earnings: Misses Expectations
- Jul 4th, 2025 5:07 am
Scroll